MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
May 15, 2019

Phase 3 Studies: Ubrogepant Decreases Headaches, Improves Patient Outcomes for Migraine

By Cassie Homer
Treatment with ubrogepant, a novel oral CGRP receptor antagonist, increased normal patient function and satisfaction and reduced incidence of migraine compared with placebo...
Phase 3 Studies: Ubrogepant Decreases Headaches, Improves Patient Outcomes for Migraine
May 8, 2019

Severe Adverse Events Common with Sequential PD-L1 Blockade and Osimertinib

By Michael Vlessides, /alert Contributor
New research has landed on a potentially troubling finding, concluding that immunotherapy with checkpoint inhibitors followed by treatment with osimertinib is associated with...
Severe Adverse Events Common with Sequential PD-L1 Blockade and Osimertinib
May 1, 2019

FDA Releases Updated Draft Guidances On Naming Biosimilars, Reference Products

By Alexa Josaphouitch, /alert Contributor
The FDA recently released new draft guidance regarding the naming of biological products. Going forward, the FDA intends to designate a proper name that is the combination of...
FDA Releases Updated Draft Guidances On Naming Biosimilars, Reference Products
April 29, 2019

Lenalidomide Plus Rituximab Ups Response in Relapsed Indolent Lymphoma

By David Douglas, Reuters Health
In patients with relapsed or refractory indolent non-Hodgkin lymphoma, adding lenalidomide to rituximab improves response...
Lenalidomide Plus Rituximab Ups Response in Relapsed Indolent Lymphoma
April 15, 2019

New T2D Agents Help Prevent, Treat Associated Kidney Disease

By Brenda L. Mooney, /alert Contributor
A recent review in Expert Opinion on Pharmacotherapy looked at the add-on value of new glucose-lowering agents compared or combined with inhibitors of the renin angiotensin aldosterone system on renal outcomes...
New T2D Agents Help Prevent, Treat Associated Kidney Disease
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

Novartis' breast cancer treatment wins FDA approval

By Reuters Staff (Reuters) - The U.S. Food and Drug Administration (FDA) said on Friday that it had approved Novartis AG's treatment in combination with a hormone therapy for postmenopausal women, as Read More »

Seniors who feel their life has purpose may live longer

By Linda Carroll (Reuters Health) - Seniors who feel their life has purpose may be less likely to die from heart, circulatory and digestive diseases and more likely to live longer, new data suggest. Read More »

Women in cardiac arrest less likely than men to get help from bystanders

By Saumya Joseph (Reuters Health) - Women who suffer cardiac arrest outside of a hospital are less likely to receive help from bystanders and have less chance of survival than men, a recent Dutch Read More »

Mandatory cognitive, psychomotor testing urged for older surgeons

By Marilynn Larkin NEW YORK (Reuters Health) - Mandatory cognitive and psychomotor testing of surgeons by at least age 65 should be implemented as part of ongoing professional evaluations, career Read More »

Prophylactic antibiotics curb infection after operative vaginal birth

By Marilynn Larkin NEW YORK (Reuters Health) - A single dose of intravenous prophylactic antibiotics can significantly reduce confirmed or suspected infection after operative vaginal birth, and Read More »

Incyte's Jakafi gets FDA approval to treat Graft vs Host Disease

By Reuters Staff (Reuters) - The U.S. Food and Drug Administration on Friday approved Incyte Corp's treatment for acute Graft versus Host disease (GvHD), an inflammatory response by the immune system Read More »

Big drug distributor pays $22 mln to settle U.S. opioid charges

By Jonathan Stempel (Reuters) - Morris & Dickson Co, one of the largest U.S. wholesale drug distributors, agreed to pay $22 million in civil penalties to settle U.S. government charges that it failed Read More »

Vision loss linked with anxiety, depression - and vice versa

By Will Boggs MD (Reuters Health) - Older adults with impaired vision are more likely to have symptoms of anxiety and depression, and older adults with symptoms of anxiety or depression are more Read More »

See all news »

Featured Video

Major Advances in Urology Care

Major Advances in Urology Care

Guy T. Bernstein, MD, FACS, of Urology Health Specialists discusses major advances in care over the next five years. 

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.